DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.32, $0.20 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $628.8 million versus the consensus estimate of $624.47 million.

GUIDANCE:

DexCom sees FY2022 revenue of $2.82-2.92 billion, versus the consensus of $2.92 billion.

• Non-GAAP Gross Profit Margin of approximately 65%
• Non-GAAP Operating Margin of approximately 16%
• Adjusted EBITDA Margin of approximately 25%

For earnings history and earnings-related data on DexCom (DXCM) click here.